Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 5
2005 5
2006 2
2007 4
2008 1
2009 2
2010 4
2011 6
2012 3
2013 6
2014 6
2015 2
2016 5
2017 5
2018 12
2019 11
2020 11
2021 12
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: COVID-19 and hematological malignancies: Volume II.
Wilde L, Binder A, Cerchione C, Isidori A. Wilde L, et al. Among authors: isidori a. Front Oncol. 2022 Oct 10;12:1044582. doi: 10.3389/fonc.2022.1044582. eCollection 2022. Front Oncol. 2022. PMID: 36300086 Free PMC article. No abstract available.
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.
Cerchione C, Romano A, Daver N, DiNardo C, Jabbour EJ, Konopleva M, Ravandi-Kashani F, Kadia T, Martelli MP, Isidori A, Martinelli G, Kantarjian H. Cerchione C, et al. Among authors: isidori a. Front Oncol. 2021 Mar 29;11:639387. doi: 10.3389/fonc.2021.639387. eCollection 2021. Front Oncol. 2021. PMID: 33898313 Free PMC article. Review.
Editorial: Strengths and Challenges of Allo-SCT in the Modern Era.
Malagola M, Greco R, Peccatori J, Isidori A, Romee R, Mohty M, Ciceri F, Russo D. Malagola M, et al. Among authors: isidori a. Front Oncol. 2022 Feb 24;12:850403. doi: 10.3389/fonc.2022.850403. eCollection 2022. Front Oncol. 2022. PMID: 35280781 Free PMC article. No abstract available.
Editorial: The Biological Landscape of Immunotherapy in AML.
Isidori A, Daver N, Curti A. Isidori A, et al. Front Oncol. 2021 Apr 15;11:671252. doi: 10.3389/fonc.2021.671252. eCollection 2021. Front Oncol. 2021. PMID: 33937085 Free PMC article. No abstract available.
Conditioning regimens in acute myeloid leukemia.
Visani G, Malagola M, Guiducci B, Lucesole M, Loscocco F, Gabucci E, Paolini S, Piccaluga PP, Isidori A. Visani G, et al. Among authors: isidori a. Expert Rev Hematol. 2014 Aug;7(4):465-79. doi: 10.1586/17474086.2014.939066. Expert Rev Hematol. 2014. PMID: 25025371 Review.
Treatment options for acute myeloid leukemia patients aged <60 years.
Visani G, Chiarucci M, Paolasini S, Loscocco F, Isidori A. Visani G, et al. Among authors: isidori a. Front Oncol. 2022 Oct 5;12:897220. doi: 10.3389/fonc.2022.897220. eCollection 2022. Front Oncol. 2022. PMID: 36276074 Free PMC article. Review.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Palandri F, Breccia M, Mazzoni C, Auteri G, Elli EM, Trawinska MM, Polverelli N, Tiribelli M, Benevolo G, Iurlo A, Tieghi A, Heidel FH, Caocci G, Beggiato E, Binotto G, Cavazzini F, Miglino M, Bosi C, Crugnola M, Bocchia M, Martino B, Pugliese N, Biondo M, Venturi M, Scaffidi L, Isidori A, Cattaneo D, Krampera M, Pane F, Cilloni D, Semenzato G, Lemoli RM, Cuneo A, Abruzzese E, Bartoletti D, Paglia S, Vianelli N, Cavo M, Bonifacio M, Palumbo GA. Palandri F, et al. Among authors: isidori a. Cancer. 2023 Jun 1;129(11):1704-1713. doi: 10.1002/cncr.34722. Epub 2023 Mar 18. Cancer. 2023. PMID: 36932983 Free article.
107 results